Stay updated on Savolitinib for MET Amplified Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page.

Latest updates to the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.4 was added to the page, replacing the previous v3.3.3 revision. No clinical trial content, eligibility criteria, or location details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded a detailed Locations section listing state sites (CA, CT, FL, IL, KS, KY, MO, NY, NC, TX) and removed the standalone per-state location headings. Removed the HHS Vulnerability Disclosure and updated the revision to v3.3.3.SummaryDifference0.9%

- Check55 days agoChange DetectedA clarifying note was added stating that PubMed publications are automatically populated from PubMed and may not all pertain to the study. The revision version information was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page no longer displays the banner about a lapse in government funding and NIH operating status; the notice previously directed users to cc.nih.gov and opm.gov for status updates.SummaryDifference0.3%

- Check77 days agoChange DetectedNo significant changes detected between the old and new page versions; the page continues to display the study’s details, objectives, eligibility criteria, and locations.SummaryDifference0.3%

- Check106 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference2%

Stay in the know with updates to Savolitinib for MET Amplified Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page.